161 related articles for article (PubMed ID: 27404053)
1. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease.
Shelygin Y; Krivokapic Z; Frolov SA; Kostarev IV; Astashov VL; Vasiliev SV; Lakhin AV; Rodoman GV; Soloviev AO; Stoyko YM; Khitaryan AG; Nechay IA
Curr Med Res Opin; 2016 Nov; 32(11):1821-1826. PubMed ID: 27404053
[TBL] [Abstract][Full Text] [Related]
2. Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial.
Kirienko A; Radak D
Int Angiol; 2016 Aug; 35(4):399-405. PubMed ID: 26576663
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.
Dimitroulopoulos D; Tsamakidis K; Xinopoulos D; Karaitianos I; Fotopoulou A; Paraskevas E
Clin Ther; 2005 Jun; 27(6):746-54. PubMed ID: 16117981
[TBL] [Abstract][Full Text] [Related]
4. The impact of micronized purified flavonoid fraction on the treatment of acute haemorrhoidal episodes.
Jiang ZM; Cao JD
Curr Med Res Opin; 2006 Jun; 22(6):1141-7. PubMed ID: 16846547
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of once-daily micronized purified flavonoid fraction 1000 mg tablet in patients with symptomatic chronic venous disease.
Kirienko A; Radak D; Maggioli A
Curr Med Res Opin; 2019 Mar; 35(3):553-557. PubMed ID: 29992831
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial.
Carpentier P; van Bellen B; Karetova D; Hanafiah H; Enriquez-Vega E; Kirienko A; Dzupina A; Sabovic M; Reina Gutierrez L; Subwongcharoen S; Tüzün H; Maggioli A
Int Angiol; 2017 Oct; 36(5):402-409. PubMed ID: 28206732
[TBL] [Abstract][Full Text] [Related]
7. Micronized purified flavonoid fraction in the treatment of hemorrhoidal disease.
Godeberge P; Sheikh P; Lohsiriwat V; Jalife A; Shelygin Y
J Comp Eff Res; 2021 Jul; 10(10):801-813. PubMed ID: 33928786
[TBL] [Abstract][Full Text] [Related]
8. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.
Zagriadskiĭ EA; Bogomazov AM; Golovko EB
Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625
[TBL] [Abstract][Full Text] [Related]
9. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
10. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis.
Sheikh P; Lohsiriwat V; Shelygin Y
Adv Ther; 2020 Jun; 37(6):2792-2812. PubMed ID: 32399811
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of micronized purified flavonoid fractions for the treatment of postoperative hemorrhoid complications: A systematic review and meta-analysis.
Fu H; Guo W; Zhou B; Liu Y; Gao Y; Li M
Phytomedicine; 2022 Sep; 104():154244. PubMed ID: 35752073
[TBL] [Abstract][Full Text] [Related]
12. MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial.
Mansilha A; Caldevilla H; Puskás A; Lucien A; Roby L; Kirienko A
Int Angiol; 2022 Dec; 41(6):464-475. PubMed ID: 36598370
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of MPFF 1000 mg oral suspension on CVD C0s-C1-related symptoms and quality of life.
Maggioli A; Carpentier P
Int Angiol; 2019 Apr; 38(2):83-89. PubMed ID: 31056892
[TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids.
Misra MC; Parshad R
Br J Surg; 2000 Jul; 87(7):868-72. PubMed ID: 10931020
[TBL] [Abstract][Full Text] [Related]
15. Treatment of haemorrhoidal disease with micronized purified flavonoid fraction and sucralfate ointment.
Amaturo A; Meucci M; Mari FS
Acta Biomed; 2020 Mar; 91(1):139-141. PubMed ID: 32191669
[TBL] [Abstract][Full Text] [Related]
16. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1.
Bogachev VY; Boldin BV; Turkin PY
Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial.
Rabe E; Agus GB; Roztocil K
Int Angiol; 2015 Oct; 34(5):428-36. PubMed ID: 25972136
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema.
Olszewski W
Angiology; 2000 Jan; 51(1):25-9. PubMed ID: 10667640
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of micronized purified flavonoid fraction for treatment of symptoms after hemorrhoidectomy: results of a randomized, controlled, clinical trial.
La Torre F; Nicolai AP
Dis Colon Rectum; 2004 May; 47(5):704-10. PubMed ID: 15037936
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of micronized purified flavonoid fractions (MPFF) for haemorrhoids: A systematic review and meta-analysis.
Aziz Z; Huin WK; Badrul Hisham MD; Tang WL; Yaacob S
Complement Ther Med; 2018 Aug; 39():49-55. PubMed ID: 30012392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
